Lymphoma | PeaceHealth


  • MAGNIFY:  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma

  • E1411:  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma 

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.